JOURNAL OF STRUCTURAL BIOLOGY, published by Academic Press Inc. Elsevier Science, is a prestigious peer-reviewed journal dedicated to advancing the field of structural biology. With an impressive Impact Factor and recognized as a Q1 journal in its category for 2023, it holds a significant position in the academic community, ranked 20th out of 49 in the Scopus Biochemistry, Genetics and Molecular Biology - Structural Biology category. The journal publishes groundbreaking research that contributes to our understanding of biological macromolecules and their complexes, span from 1990 and continuing through 2024. Researchers and professionals alike rely on this journal for high-quality articles that cover a wide array of techniques including X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy. Although it does not operate under an Open Access model, the journal remains a vital resource for those in academia and industry searching for the latest findings and methodologies in structural biology.

Letters in Drug Design & Discovery is an esteemed journal dedicated to advancing the fields of Drug Discovery and Molecular Medicine. Published by Bentham Science Publishers, this journal offers a platform for the dissemination of innovative research and advanced methodologies, enhancing collaboration among researchers and professionals in pharmaceutical sciences. Despite its current Q4 ranking in Drug Discovery and Molecular Medicine and Q3 in Pharmaceutical Science for 2023, the journal is committed to improving its presence in the academic community by providing quality, peer-reviewed publications that cover various aspects of drug design and discovery, including novel therapeutic approaches and methodologies. With a focus on both foundational and cutting-edge research from around the globe, Letters in Drug Design & Discovery is pivotal for those seeking to stay abreast of developments in drug development and molecular research. Researchers are encouraged to submit their work, engage with the burgeoning field, and contribute to the ongoing dialogue driven by this journal, which spans the years from 2005 to 2024. While the journal does not currently offer open access, its contributions remain accessible to a wide range of academic and professional audiences.

STRUCTURE is a premier academic journal published by CELL PRESS, dedicated to advancing the field of structural biology and molecular biology since its inception in 1993. With an impressive reputation, it is recognized as a Q1 journal in both Molecular Biology and Structural Biology categories, reflecting its high impact within the academic community. The journal holds a significant position in Scopus rankings, placing 10th among 49 in Structural Biology and 100th among 410 in Molecular Biology, marking it as a key resource with a strong influence on ongoing research. Researchers and professionals alike will find STRUCTURE an invaluable platform for disseminating cutting-edge findings related to protein structure, dynamics, and interactions, fostering insights that can lead to groundbreaking applications in medicine and biotechnology. Although the journal follows a traditional subscription model, it continues to attract a diverse array of submissions, ensuring a vibrant exchange of knowledge in the ever-evolving landscape of structural and molecular biology. Access to its content can enhance the understanding of intricate biological mechanisms, making it essential reading for experts, students, and anyone passionate about the molecular underpinnings of life.

PROTEIN SCIENCE, published by Wiley, is a premier journal dedicated to the field of biochemistry, molecular biology, and medicine, boasting an impressive impact factor that reflects its influence and importance within the academic community. Established in 1992, the journal has continuously provided a platform for high-quality research, with a current classification in the top quartile (Q1) for its critical contributions to the understanding of protein structure and function, as well as its applications in health and disease. With a Scopus ranking placing it in the 91st percentile among its peers, PROTEIN SCIENCE publishes cutting-edge studies and reviews that are essential for researchers, professionals, and students seeking to advance their knowledge in protein research. Although it does not currently offer open access options, the journal remains dedicated to disseminating vital findings that support the ongoing advancements in molecular biology and biochemistry. Researchers can count on PROTEIN SCIENCE for consistently rigorous peer-reviewed content that fosters meaningful dialog and innovation in the life sciences.

CURRENT DRUG TARGETS is a leading peer-reviewed journal dedicated to advancements in the fields of Clinical Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. Published by Bentham Science Publishers Ltd, this esteemed journal has solidified its position in the academic community with a 2023 Q2 ranking in several categories, highlighting its influence and relevance in drug research and development. With an ISSN of 1389-4501 and E-ISSN 1873-5592, CURRENT DRUG TARGETS facilitates the dissemination of high-quality articles that explore novel therapeutic strategies and drug design principles. Catered to researchers, professionals, and students, the journal has a commitment to advancing knowledge while addressing contemporary challenges in pharmacological sciences. As it converges from 2000 to 2024, CURRENT DRUG TARGETS remains a vital resource in understanding the complexities of drug action and interaction, making it indispensable for anyone pursuing cutting-edge research in related disciplines.

Doklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.

INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS is a well-regarded academic journal that serves as a vital platform for researchers in the fields of biochemistry and biophysics. Published by the NATL INST SCIENCE COMMUNICATION-NISCAIR since its inception in 1972, this Open Access journal has committed itself to disseminating high-quality research and advancements in these dynamic fields, allowing readers worldwide to access vital findings since 2009. The journal maintains a robust presence in the academic landscape, achieving noteworthy rankings in 2023, placing it in the Q4 category for Biochemistry and Q3 for both Biophysics and miscellaneous Medicine, alongside its respectable Scopus rankings. With an emphasis on original research articles, reviews, and educational contributions, the INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS plays an essential role in fostering scientific dialogue and collaboration among professionals and students alike. For scholars seeking to stay at the forefront of biochemistry and biophysics research, this journal is an indispensable resource that fosters knowledge exchange and elevates the field on both a national and international scale.

AIMS Molecular Science is a premier open-access journal published by the American Institute of Mathematical Sciences (AIMS), dedicated to the advancement and dissemination of high-quality research in the field of molecular science. Since its inception in 2014, this journal has established itself as a vital platform for researchers and professionals aiming to share their findings in molecular biology, chemistry, and interdisciplinary studies related to these domains. With an increasing focus on the accessibility of scientific knowledge, AIMS Molecular Science supports the open-access movement, ensuring that all published articles are freely available to the global research community. The journal emphasizes originality and significance in research, promoting innovative scientific methodologies and applications. By fostering collaboration and dialogue among scientists, AIMS Molecular Science plays a crucial role in advancing understanding and stimulating progress in molecular sciences.

PROTEINS - STRUCTURE FUNCTION AND BIOINFORMATICS, published by WILEY, is a leading journal in the fields of biochemistry, molecular biology, and structural biology, recognized for its significant contribution to protein research since its inception in 1986. With its impressive rankings in the Q1 category for Biochemistry and Q2 for both Molecular Biology and Structural Biology in 2023, the journal serves as an essential resource for researchers and professionals seeking to explore the intricate relationships between protein structures and their functions. The journal, based in the United States, operates without an Open Access model, ensuring a curated selection of high-quality peer-reviewed articles that drive innovation and collaboration in the scientific community. Engaging with the robust content of PROTEINS not only bolsters academic scholarship but also opens avenues for groundbreaking discoveries that are pivotal in the advancing field of bioinformatics.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.